Primal Therapies, Inc.
Biotechnology company · Boise, Idaho, United States
Primal Therapies, Inc. is a biotechnology company headquartered in Boise, Idaho, United States. Its earliest recorded incorporation is in 2012. It has received 1 US government small-business research award (SBIR/STTR) from health agencies, $206,479 in total, most recently in 2017. It has reported private securities offerings to the US SEC, most recently $677,022 sold in a notice filed in 2016.
Primal Therapies at a glance
What does Primal Therapies do?
US government research funding
1 SBIR/STTR small-business research award from US health agencies, $206,479 in total (2017). NIH funding came from the National Institute on Aging.
Private fundraising reported to the SEC
1 Form D notice; the most recent reported $677,022 sold (2016).
Frequently asked questions about Primal Therapies
Where is Primal Therapies headquartered?
Primal Therapies, Inc. is headquartered in Boise, Idaho, United States.
What does Primal Therapies do?
Primal Therapies, Inc. is a biotechnology company.
When was Primal Therapies founded?
The earliest incorporation on record for Primal Therapies, Inc. is in 2012, according to public company registers.
Similar companies
- Recursion PharmaceuticalsSalt Lake City, Utah, United States
- Vericel CorpBurlington, Massachusetts, United States
- SAB Biotherapeutics, Inc.Miami Beach, Florida, United States
- Adaptive Biotechnologies CorpSeattle, Washington, United States
- Inhibikase Therapeutics, Inc.Wilmington, Delaware, United States
- Cognition Therapeutics IncPurchase, New York, United States
- Agenus IncLexington, Massachusetts, United States
- Vaxcyte, Inc.San Carlos, California, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-25. Data licences